95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.54%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-33.72%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.05%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.05%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-89.31%
Negative net income growth while AEM stands at 242.98%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-88.89%
Negative EPS growth while AEM is at 250.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-88.89%
Negative diluted EPS growth while AEM is at 250.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.10%
Share reduction more than 1.5x AEM's 0.32%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.08%
Diluted share count expanding well above AEM's 0.16%. Michael Burry would fear significant dilution to existing owners' stakes.
-47.61%
Dividend reduction while AEM stands at 8.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-19.81%
Negative OCF growth while AEM is at 14.56%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
16.12%
Positive FCF growth while AEM is negative. John Neff would see a strong competitive edge in net cash generation.
163.47%
10Y revenue/share CAGR at 50-75% of AEM's 240.72%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-10.49%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
10.49%
Positive 3Y CAGR while AEM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
171.76%
10Y OCF/share CAGR under 50% of AEM's 373.04%. Michael Burry would worry about a persistent underperformance in cash creation.
-26.75%
Negative 5Y OCF/share CAGR while AEM is at 25.89%. Joel Greenblatt would question the firm’s operational model or cost structure.
-0.73%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-6.14%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-64.60%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
132.33%
Below 50% of AEM's 1125.31%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
222.43%
10Y equity/share CAGR above 1.5x AEM's 40.85%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
25.26%
5Y equity/share CAGR above 1.5x AEM's 6.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
8.87%
3Y equity/share CAGR at 75-90% of AEM's 10.74%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-23.77%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
86.39%
3Y dividend/share CAGR above 1.5x AEM's 27.44%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-84.01%
Firm’s AR is declining while AEM shows 1.34%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
5.95%
Asset growth above 1.5x AEM's 0.93%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.00%
We have a declining book value while AEM shows 0.01%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
44.33%
Debt growth far above AEM's 0.08%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-30.81%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.